Influenza Pipeline | Clinical Trials, Key Companies

DelveInsight's, "Influenza - Pipeline Insight, 2023," report provides comprehensive insights about 120+ companies and 120+ pipeline drugs in Influenza pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Download the sample @
https://www.delveinsight.com/sample-request/influenza-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Influenza Pipeline Overview
Influenza, one of the most common infectious diseases, is a highly contagious airborne disease that occurs in seasonal epidemics and manifests as an acute febrile illness with variable degrees of systemic symptoms, ranging from mild fatigue to respiratory failure and death. Influenza causes significant loss of workdays, human suffering, and mortality. The CDC documented that seasonal influenza was responsible for 24,000 to 62,000 deaths during the 2019-2020 season.

Influenza Pipeline Pipeline Analysis: Drug Profile
Moderna
SAB Biotherapeutics
ENA Respiratory Pty Ltd
Codagenix
AlloVir
Osivax
And many others

Discover more about the emerging Influenza Pipeline Treatment Drugs @ https://www.delveinsight.com/sample-request/influenza-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Influenza Pipeline Pipeline Therapeutics Assessment
Phases
DelveInsight's Report covers around 10+ products under different phases of clinical development like
Late-stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I) along with the details of
Pre-clinical and Discovery stage candidates
Discontinued and inactive candidates

Route of Administration
Influenza Pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
Inhalation
Inhalation/Intravenous/Oral
Intranasal
Intravenous
Intravenous/ Subcutaneous

Molecule Type
Products have been categorized under various Molecule types such as
Antibody
Antisense oligonucleotides
Immunotherapy
Monoclonal antibody
Peptides
Protein
Recombinant protein
Small molecule
Stem Cell
Vaccine

Product Type
Drugs have been categorized under various product types like Mono, Combination, and Mono/Combination.

Scope of the Influenza Pipeline Pipeline Report
Coverage: Global
Key Influenza Pipeline Companies: Pfizer, Janssen Pharmaceutical and many others
Key Influenza Pipeline Pipeline Therapies Elranatamab, Felzartamab, and many others
Find out more about the @ Influenza Pipeline Clinical Trials @ https://www.delveinsight.com/report-store/influenza-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Table of Contents
1. Influenza Pipeline Introduction
2. Influenza Pipeline Executive Summary
3. Influenza Pipeline Overview
4. Influenza Pipeline Pipeline Therapeutics
5. Influenza Pipeline Late-Stage Products (Phase III)
6. Influenza Pipeline Mid-Stage Products (Phase II)
7. Influenza Pipeline Early Stage Products (Phase I/II)
8. Influenza Pipeline Preclinical Stage Products
9. Influenza Pipeline Discovery Stage Products
10. Influenza Pipeline Therapeutic Assessment
11. Influenza Pipeline Inactive Products
12. Influenza Pipeline Collaborations Assessment- Licensing / Partnering / Funding
13. Influenza Pipeline Unmet Needs
14. Influenza Pipeline Market Drivers and Barriers
15. Appendix
16. About DelveInsight

DelveInsight Business Research LLP
Adya Kaul
info@delveinsight.com
https://www.delveinsight.com

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences.

This release was published on openPR.